CN Patent

CN112812052B — 一种治疗溃疡性结肠炎的化合物及其制备方法和用途

Assigned to Chengdu Achi Biopharmaceutical Technology Co ltd · Expires 2023-12-01 · 2y expired

What this patent protects

本发明提供了一种治疗溃疡性结肠炎的化合物，具有式I所示结构。本发明提供的化合物能够显著抑制患结肠炎时结肠组织中TNF‑α、IL‑1β和IL‑6等促炎因子的异常分泌，抑制炎性细胞浸润，维持肠上皮和隐窝腺的完整，能够有效减轻炎症，改善结肠缩短和肠壁增厚症状，在制备治疗溃疡性结肠炎的药物中具有优异的潜在应用价值，为临床提供了新的选择。

USPTO Abstract

本发明提供了一种治疗溃疡性结肠炎的化合物，具有式I所示结构。本发明提供的化合物能够显著抑制患结肠炎时结肠组织中TNF‑α、IL‑1β和IL‑6等促炎因子的异常分泌，抑制炎性细胞浸润，维持肠上皮和隐窝腺的完整，能够有效减轻炎症，改善结肠缩短和肠壁增厚症状，在制备治疗溃疡性结肠炎的药物中具有优异的潜在应用价值，为临床提供了新的选择。

Drugs covered by this patent

Patent Metadata

Patent number
CN112812052B
Jurisdiction
CN
Classification
—
Expires
2023-12-01
Drug substance claim
No
Drug product claim
No
Assignee
Chengdu Achi Biopharmaceutical Technology Co ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.